The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(Pyridin-2-yl)-N'-(3,4,5-trimethoxybenzylidene)piperazine-1-carbohydrazide ID: ALA4800161
PubChem CID: 162676580
Max Phase: Preclinical
Molecular Formula: C20H25N5O4
Molecular Weight: 399.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=N/NC(=O)N2CCN(c3ccccn3)CC2)cc(OC)c1OC
Standard InChI: InChI=1S/C20H25N5O4/c1-27-16-12-15(13-17(28-2)19(16)29-3)14-22-23-20(26)25-10-8-24(9-11-25)18-6-4-5-7-21-18/h4-7,12-14H,8-11H2,1-3H3,(H,23,26)/b22-14+
Standard InChI Key: ZPJWCVJWFWNSQI-HYARGMPZSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
10.8903 -13.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8892 -14.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5972 -14.7534 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3069 -14.3440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3041 -13.5213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5954 -13.1160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1847 -14.7502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4775 -14.3389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7716 -14.7434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7667 -15.5609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4739 -15.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1860 -15.5661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0571 -15.9663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3513 -15.5545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0534 -16.7835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6417 -15.9598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9359 -15.5480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2263 -15.9534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5230 -15.5384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8139 -15.9430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8097 -16.7611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5205 -17.1728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2267 -16.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1083 -15.5309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1124 -14.7137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1007 -17.1674 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3943 -16.7565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5197 -17.9900 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8115 -18.3978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
2 7 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
20 24 1 0
24 25 1 0
21 26 1 0
26 27 1 0
22 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 399.45Molecular Weight (Monoisotopic): 399.1907AlogP: 1.97#Rotatable Bonds: 6Polar Surface Area: 88.52Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.78CX Basic pKa: 6.42CX LogP: 1.86CX LogD: 1.82Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.59Np Likeness Score: -1.63
References 1. Tripathi A,Choubey PK,Sharma P,Seth A,Tripathi PN,Tripathi MK,Prajapati SK,Krishnamurthy S,Shrivastava SK. (2019) Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease., 183 [PMID:31561043 ] [10.1016/j.ejmech.2019.111707 ]